Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-25-008974
Filing Date
2025-03-25
Accepted
2025-03-25 19:38:53
Documents
1
Period of Report
2025-03-18

Document Format Files

Seq Description Document Type Size
1 form3-03252025_110350.html 3  
1 form3-03252025_110350.xml 3 4081
  Complete submission text file 0001415889-25-008974.txt   6414
Mailing Address 628 MIDDLEFIELD ROAD PALO ALTO CA 94301
Business Address 628 MIDDLEFIELD ROAD PALO ALTO CA 94301 (650) 285-4270
Samsara BioCapital, L.P. (Reporting) CIK: 0001699737 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-39409 | Film No.: 25769744

Mailing Address 628 MIDDLEFIELD ROAD PALO ALTO CA 94301
Business Address 628 MIDDLEFIELD ROAD PALO ALTO CA 94301 650-249-2727
Kalaris Therapeutics, Inc. (Issuer) CIK: 0001754068 (see all company filings)

EIN.: 831971007 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 251 CHURCHILL AVENUE PALO ALTO CA 94301
Business Address 251 CHURCHILL AVENUE PALO ALTO CA 94301 (650) 843-5000
Samsara BioCapital GP, LLC (Reporting) CIK: 0001888829 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-39409 | Film No.: 25769745